UB Paderborn / Katalog / Suche / in CDI

Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy

Journal of the American College of Cardiology, 2013-12, Vol.62 (24), p.2284-2293

2013

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease

Journal of the American College of Cardiology, 2013-03, Vol.61 (9), p.926-932

2013

Link zum Volltext

Verfügbarkeit prüfen

Improving the Primary Prevention of Cardiovascular Events by Using Biomarkers to Identify Individuals With Silent Heart Disease

Journal of the American College of Cardiology, 2012-09, Vol.60 (11), p.960-968

2012

Link zum Volltext

Verfügbarkeit prüfen

Left Ventricular Hypertrophy in COPD Without Hypoxemia

Chest, 2013, Vol.143 (1), p.91-97

2013

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia in a Patient With Carcinoid Syndrome

Journal of the American College of Cardiology, 2013-10, Vol.62 (17), p.e241-e241

2013

Link zum Volltext

Verfügbarkeit prüfen

The Eustachian Ridge: Not an Innocent Bystander

JACC. Cardiovascular imaging, 2014-10, Vol.7 (10), p.1062-1063

2014

Link zum Volltext

Verfügbarkeit prüfen

Renin–angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular block

Heart rhythm, 2012-04, Vol.9 (4), p.505-510

2012

Link zum Volltext

Verfügbarkeit prüfen

Intraaortic balloon support for cardiogenic shock

The New England journal of medicine, 2013-01, Vol.368 (1), p.80

2013

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Renin-Angiotensin-Aldosterone System Blockade on Heart Failure Outcomes and Mortality in Patients Identified to Have Aortic Regurgitation

Journal of the American College of Cardiology, 2011-11, Vol.58 (20), p.2084-2091

2011

Link zum Volltext

Verfügbarkeit prüfen

The assessment of mitral valve disease: a guideline from the British Society of Echocardiography

Echo research and practice, 2021-09, Vol.8 (1), p.G87-G136

2021

Link zum Volltext

Verfügbarkeit prüfen

Reducing Cardiovascular Risk in Patients Following MI with Eplerenone

Clinical Medicine Insights: Therapeutics, 2010-01, Vol.2010 (2), p.CMT.S5231

2010

Link zum Volltext

Verfügbarkeit prüfen

Intraaortic Balloon Support for Cardiogenic Shock

The New England journal of medicine, 2013-01, Vol.368 (1), p.80-81

2013

Link zum Volltext

Verfügbarkeit prüfen

81 Balloon Aortic Valvuloplasty in the Tavr ERA – Single Tertiary Centre Experience: Abstract 81 Table 1

Heart (British Cardiac Society), 2014-06, Vol.100 (Suppl 3), p.A47-A48

2014

Link zum Volltext

Verfügbarkeit prüfen

Real-world performance and accuracy of stress echocardiography: the EVAREST observational multi-centre study

European heart journal cardiovascular imaging, 2022-04, Vol.23 (5), p.689-698

2022

Link zum Volltext

Verfügbarkeit prüfen

Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room?

Chest, 2013-01, Vol.143 (1), p.91-97

2013

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Renin-Angiotensin-Aldosterone System Blockade on Heart Failure Outcomes and Mortality in Patients Identified to Have Aortic Regurgitation: A Large Population Cohort Study

Journal of the American College of Cardiology, 2011-11, Vol.58 (20), p.2084-2091

2011

Link zum Volltext

Verfügbarkeit prüfen

MRI of the left atrium at 3T: evaluation of measurement reproducibility in healthy volunteers and patients with cardiovascular disease

Acta radiologica (1987), 2016-12, Vol.57 (12), p.1468-1475

2016

Link zum Volltext

Verfügbarkeit prüfen

Real world hospital costs following stress echocardiography in the UK: a costing study from the EVAREST/BSE-NSTEP multi-entre study

Echo research and practice, 2023-05, Vol.10 (1), p.8-8

2023

Link zum Volltext

Verfügbarkeit prüfen

Real world hospital costs following stress echocardiography in the UK: a costing study from the EVAREST/BSE-NSTEP multi-centre study

Echo research and practice, 2023-12, Vol.10 (1), p.8-11, Article 8

2023

Link zum Volltext

Verfügbarkeit prüfen

The effects of xanthine oxidase inhibitors on left ventricular mass and endothelial function in patients with ischaemic heart disease

Rekhraj, Sushma

2014

Link zum Volltext
ProQuest

CAN MICROALBUMINURIA IDENTIFY SILENT ‘PANCARDIAC’ TARGET ORGAN DAMAGE IN A NON-DIABETIC PRIMARY PREVENTION POPULATION?

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E605-E605

2011

Link zum Volltext

Verfügbarkeit prüfen

ALLOPURINOL REDUCES LEFT VENTRICULAR MASS IN PATIENTS WITH TYPE II DIABETES AND LEFT VENTRICULAR HYPERTROPHY

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1256-E1256

2013

Link zum Volltext

Verfügbarkeit prüfen

CAN B-TYPE NATRIURETIC PEPTIDE IDENTIFY STRESS INDUCED MYOCARDIAL ISCHEMIA IN THE PRESENCE OF SYSTOLIC DYSFUNCTION?

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E1119-E1119

2011

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation in diabetes: A cause for concern?

Journal of diabetes mellitus, 2012, Vol.2 (4), p.378-385

2012

Link zum Volltext

Verfügbarkeit prüfen

Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal

Arthritis and rheumatism, 2012-02, Vol.64 (2), p.327-338

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy

High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease

Improving the Primary Prevention of Cardiovascular Events by Using Biomarkers to Identify Individuals With Silent Heart Disease

Left Ventricular Hypertrophy in COPD Without Hypoxemia

Hypoxia in a Patient With Carcinoid Syndrome

The Eustachian Ridge: Not an Innocent Bystander

Renin–angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular block

Intraaortic balloon support for cardiogenic shock

The Impact of Renin-Angiotensin-Aldosterone System Blockade on Heart Failure Outcomes and Mortality in Patients Identified to Have Aortic Regurgitation

The assessment of mitral valve disease: a guideline from the British Society of Echocardiography

Reducing Cardiovascular Risk in Patients Following MI with Eplerenone

Intraaortic Balloon Support for Cardiogenic Shock

81 Balloon Aortic Valvuloplasty in the Tavr ERA – Single Tertiary Centre Experience: Abstract 81 Table 1

Real-world performance and accuracy of stress echocardiography: the EVAREST observational multi-centre study

Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room?

The Impact of Renin-Angiotensin-Aldosterone System Blockade on Heart Failure Outcomes and Mortality in Patients Identified to Have Aortic Regurgitation: A Large Population Cohort Study

MRI of the left atrium at 3T: evaluation of measurement reproducibility in healthy volunteers and patients with cardiovascular disease

Real world hospital costs following stress echocardiography in the UK: a costing study from the EVAREST/BSE-NSTEP multi-entre study

Real world hospital costs following stress echocardiography in the UK: a costing study from the EVAREST/BSE-NSTEP multi-centre study

The effects of xanthine oxidase inhibitors on left ventricular mass and endothelial function in patients with ischaemic heart disease

CAN MICROALBUMINURIA IDENTIFY SILENT ‘PANCARDIAC’ TARGET ORGAN DAMAGE IN A NON-DIABETIC PRIMARY PREVENTION POPULATION?

ALLOPURINOL REDUCES LEFT VENTRICULAR MASS IN PATIENTS WITH TYPE II DIABETES AND LEFT VENTRICULAR HYPERTROPHY

CAN B-TYPE NATRIURETIC PEPTIDE IDENTIFY STRESS INDUCED MYOCARDIAL ISCHEMIA IN THE PRESENCE OF SYSTOLIC DYSFUNCTION?

Atrial fibrillation in diabetes: A cause for concern?

Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal

Suchergebnisse filtern